These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6781999)

  • 21. Plasma 25-hydroxy-vitamin D in familial hypercholesterolemic children receiving colestipol resin.
    Tsang RC; Roginsky MS; Mellies MJ; Glueck CJ
    Pediatr Res; 1978 Oct; 12(10):980-2. PubMed ID: 724301
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of colestipol on plasma lipids in patients affected by type Ii primary hyperlipoproteinaemia (author's transl)].
    Drouin P; Sauvanet JP; Lambert D; Mejean L; Debry G
    Therapie; 1980; 35(4):457-64. PubMed ID: 7466730
    [No Abstract]   [Full Text] [Related]  

  • 23. Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia.
    Miller NE; Clifton-Bligh P; Nestel PJ; Whyte HM
    Med J Aust; 1973 Jun; 1(25):1223-7. PubMed ID: 4579666
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of pharmaceutical care on optimum colestipol treatment in elderly hypercholesterolemic veterans.
    Konzem SL; Gray DR; Kashyap ML
    Pharmacotherapy; 1997; 17(3):576-83. PubMed ID: 9165562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The long-term effects of colestipol hydrochloride on serum and lipoprotein lipids in patients with heterozygous familial hypercholesterolemia (author's transl)].
    Wakasugi T; Sakai T; Watanabe A; Tatami R; Ueda K; Ueda R; Kametani T; Haba T; Koizumi J; Miyamoto S; Mabuchi H; Takeda R; Sakai Y; Yoshimura A; Takegoshi T; Ohta M; Ono S; Ohka T; Takeshita H
    Nihon Ronen Igakkai Zasshi; 1981 Nov; 18(6):432-40. PubMed ID: 7339082
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of combined treatment with lovastatin and colestipol on serum lipids and lipoproteins].
    Kłosiewicz-Latoszek L; Nowicka G; Szostak WB
    Wiad Lek; 1993 Aug; 46(15-16):581-5. PubMed ID: 7975581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bile acid sequestrants and cholesterol.
    Schon P
    N Z Med J; 1990 Apr; 103(887):163. PubMed ID: 2111529
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.
    Crouse JR
    Am J Med; 1987 Aug; 83(2):243-8. PubMed ID: 3618626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of colestipol, a new bile-acid-sequestering resin, on cholesterol metabolism in man.
    Miller NE; Clifton-Bligh P; Nestel PJ
    J Lab Clin Med; 1973 Dec; 82(6):876-90. PubMed ID: 4758739
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term trial with colestipol plus clofibrate in familial hypercholesterolemia.
    Fellin R; Baggio G; Briani G; Baiocchi MR; Manzato E; Baldo G; Crepaldi G
    Atherosclerosis; 1978 Feb; 29(2):241-9. PubMed ID: 348207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of lipid-lowering therapy on the progression of coronary atherosclerosis assessed by scheduled repetitive coronary arteriography.
    Nash DT; Gensini G; Esente P
    Int J Cardiol; 1982; 2(1):43-55. PubMed ID: 7129689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of hypercholesterolemia. Can it retard atherogenesis?
    Untereker WJ
    Int J Cardiol; 1982; 2(1):57-9. PubMed ID: 7129690
    [No Abstract]   [Full Text] [Related]  

  • 34. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia.
    Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K
    Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term effects of weight reduction on body weight and metabolic parameters in adipose non-diabetics and adipose maturity-onset diabetics].
    Schneider H; Zschornak M; Neumann I; Haller H
    Z Gesamte Inn Med; 1981 Apr; 36(7):301-4. PubMed ID: 7281831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of colestipol or cholestyramine on serum cholesterol and triglycerides in a long-term controlled study.
    Ryan JR; Jain A
    J Clin Pharmacol New Drugs; 1972 Jul; 12(7):268-73. PubMed ID: 4557535
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of colestipol when combined with clofibrate in the treatment of severe hyperlipidemia. Short-term and long-term studies.
    Lithell H; Vessby B; Boberg J; Hellsing K
    Atherosclerosis; 1980 Oct; 37(2):175-86. PubMed ID: 7000089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experiences with a new cholesterolemia-lowering resin, Colestipol (U-26, 597 A. Upjohn)].
    Muls E; Lemmens P
    Acta Clin Belg; 1975; 30(5):409-14. PubMed ID: 1221747
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperlipidemia - a diabetic emergency.
    Saudek CD
    Geriatrics; 1982 Feb; 37(2):81-9. PubMed ID: 7056473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term cholesterol-lowering effect of colestipol resin in humans.
    Gross L; Figueredo R
    J Am Geriatr Soc; 1973 Dec; 21(12):552-6. PubMed ID: 4584170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.